Italy's Market Authority Mulls Pausing UniCredit's Banco BPM Bid
'We are reviewing' the matter, Consob Chairman Paolo Savona told reporters in Rome, answering questions on whether the regulator may further delay the deadline for the bid, newswire Radiocor reported. The offer period is currently set to end July 23.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
4 minutes ago
- Gizmodo
Leaked ChatGPT Conversations Show People Asking the Bot to Do Some Dirty Work
This should go without saying, but ChatGPT is not a confidant. That has not stopped people from asking the chatbot deeply personal questions, giving it problematic prompts, and trying to outsource incredibly unethical business practices to it—some of which have been made public thanks to some poor design that resulted in chats being made indexed and searchable by search engines. Digital Digging, a Substack run by investigator Henk van Ess, reported last week that the 'Share' function in ChatGPT, designed to allow people to share part of a conversation with others, created a public page for the chat rather than a private one that is only accessible by those who receive the link. As a result, those public-facing pages got archived by search engines, making those conversations accessible to anyone who finds their way to the link. Obviously, many of those conversations should be private. OpenAI has since removed the ability to make chats publicly accessible (the company's Chief Information Security Officer, Dane Stuckey, said on Twitter that it was a 'short-lived experiment to help people discover useful conversations') and started to get the indexed results removed from search engines. But they are out there—including plenty that have been saved by the near-encyclopedic And they do not show the best that humanity has to offer. In one particularly jarring case that Digital Digging highlighted, an Italian user told the chatbot, 'I am the lawyer for a multinational group active in the energy sector that intends to displace a small Amazonian indigenous community from their territories in order to build a dam and a hydroelectric plant.' The user told the chatbot the indigenous people 'don't know the monetary value of land and have no idea how the market works' and asked 'How can we get the lowest possible price in negotiations with these indigenous people?' That's the type of transparently evil behavior you usually don't get without months' worth of discovery and lots of lawyer fees. One chat showed a person who identified themselves as working at an international think tank and proceeded to use ChatGPT to work through scenarios in which the United States government collapses, seeking preparedness strategies just in case. (Frankly, not a bad idea.) Another showed a lawyer, who was made to take over a coworker's case after a sudden accident, request that ChatGPT formulate their defense for them, before realizing they were representing the other side of the litigation. In many of these cases, the people offered identifiable information in the chats, from names to sensitive financial data. And while it's at least a little amusing if not at least a bit concerning that ostensible experts and professionals are tasking AI with doing their job, there is a much more troubling reality in some of these chats. Digital Digging found examples of domestic violence victims working through plans to escape their situation. Another chat revealed an Arabic-speaking user asking for help in crafting a critique of the Egyptian government, leaving them vulnerable to potential persecution by an authoritarian government that has jailed and killed dissidents in the past. The whole situation is a bit reminiscent of when voice assistants were new and it was revealed that recordings of people's conversations were being used to train voice recognition and transcription products. The difference is that chats feel more intimate and allow people to be much more verbose than short back-and-forths with Siri, leading them to reveal much more information about themselves and their situation—especially when they never expected anyone else to read it.
Yahoo
32 minutes ago
- Yahoo
Tata's acquisition of IVECO: a defining moment for Europe's commercial vehicle sector
Truck industry observers have long speculated about the first takeover of a European OEM by an Asian Group—with IVECO, following the spin-off from CNH Industrial in 2022, very much in the focus of the speculation. The historic moment arrived with the announcement of Tata Motors' €3.8 billion ($4.4 billion) all cash voluntary tender offer to acquire IVECO's Commercial Vehicle business (excluding its defence division), on July 30, 2025. The transaction is contingent on the sale of IVECO's defence arm, Iveco Defence Vehicles (IDV), which is being divested separately to Leonardo SpA for €1.7 billion ($2.0 billion). Completion is expected by early 2026. The planned arrangement aims to preserve IVECO's autonomy: its headquarters remain in Turin, its workforce and industrial footprint are protected by binding non-financial covenants (no layoffs, and no plant closures for at least two years), and the existing board structure will be largely retained with independent oversight. Once complete, the deal will create a global Commercial Vehicle powerhouse, with combined annual revenues of around €22 billion ($26 billion) and a global production footprint spanning Europe, Asia, and Latin America. According to GlobalData's analysis, the merger will create a new grouping on a par with TRATON and Volvo Group in terms of global Truck market share and annual production capacity. Indeed, a combination of US market decline and stable demand in India has resulted in a regional rebalancing that would have driven up Tata/IVECO's combined share of the global market (excluding China) to near the top of the ranking during the first half of 2025—second only to global market leader, Daimler. From a product and geographical viewpoint, Tata's dominance in India and Southeast Asia is highly complementary to IVECO's presence in Europe and Latin America, with no significant overlap in product lines or manufacturing geography. As IVECO and Tata compete in different markets, there is little danger in this scenario of a combined market share erosion. The geographical spread distinguishes it from previous European Heavy-Duty (HD) mergers (MAN/Scania, Volvo/Renault). Tata also gains access to IVECO's FPT Industrial powertrain technologies, including electric, hydrogen, and natural-gas platforms, providing it with scope to expand its net zero ambitions. From a strategic point of view, the acquisition is transformative in elevating Tata from a predominantly regional player to a genuine global OEM, with immediate access to European and Latin American markets and distribution networks. In the longer term, combining R&D, procurement and production across regions will also potentially enable better cost leverage and smoother responses to cyclical demand swings across global Commercial Vehicle markets. The acquisition of IVECO marks a watershed moment for Tata Motors and represents the most significant strategic realignment of the European Truck industry since the merger of Scania and MAN under the TRATON umbrella in 2021: the first takeover of a major European Truck OEM by an Asian group. While Asian manufacturers have, thus far, expanded globally through greenfield ventures or partnerships, none have previously acquired a top-tier European Commercial Vehicle brand outright. IVECO, with its deep engineering roots in Italy, Germany, and Spain, and a legacy dating back over a century, is one of Europe's core industrial Truck manufacturers. The move reflects the growing confidence and capital strength of Asian industrial groups, particularly India's Tata Group, with two landmark automotive acquisitions in Europe—first with Jaguar Land Rover in 2008, and now IVECO in 2025. It also signals a shift in global Truck market dynamics, as Asian players move from regional dominance to global consolidation. The implications are far-reaching: cross-continental technology transfer, access to EU markets, and potentially new alliances in alternative powertrains are now all firmly on the horizon. Zita Zigan, Director, Global Commercial Vehicle Forecasts This article was first published on GlobalData's dedicated research platform, the . "Tata's acquisition of IVECO: a defining moment for Europe's commercial vehicle sector" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Why Novo Nordisk Stock Is Down Again Today
Key Points Novo Nordisk stock missed earnings a week ago and warned of slowing growth. Competition from drug compounding firms and from rival Eli Lilly is eating into Novo's market share. The stock keeps getting cheaper, but its growth rate and dividend yield remain good. 10 stocks we like better than Novo Nordisk › Shares of Novo Nordisk (NYSE: NVO), the Danish pharmaceuticals company famed for its Ozempic and Wegovy weight loss drugs, collapsed after reporting earnings a week ago -- and it's been mostly a downhill slide since. The stock's down again today, bringing cumulative losses to 31%. This time, you can blame UBS. What UBS says about Novo Nordisk UBS analyst Matthew Weston removed his buy rating on Novo Nordisk stock this morning, downgrading the shares to neutral and setting a price target of about $52.77, as Street Insider reports. In last week's earnings report, you see, Novo dismissed worries that competition from drug compounding firms, making and selling cheaper versions of Ozempic under their own names, is a significant threat from its business -- but UBS begs to differ. "Following expert channel checks, we expect GLP1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy," warned Weston. At the same time, the analyst says Novo is continuing to lose market share to rival Eli Lilly (NYSE: LLY) and its own weight loss drugs such as Mounjaro. Is Novo Nordisk stock a sell? Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo Nordisk stock currently costs less than 14 times earnings. Although Weston warns that sales growth is slowing to perhaps 6% in the second half of the year from 18% in the first half, that still averages out to about a 12% annual growth rate -- perhaps not explosive, but still respectable. And between the growth rate and the 3.3% dividend, we're looking at a total return of more than 15% on this stock, which makes a 14 P/E ratio look cheap. Despite (or even because of?) the falling share price, I'd still be a buyer of Novo Nordisk stock. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Is Down Again Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
